Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Richert

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|December 22, 2020
Influence of the Antiretroviral Regimen on the Early Changes in Plasma HIV RNA and Immune Activation at Initiation of Antiretroviral Therapy in Naïve HIV-1-Infected PatientsAssia Samri, Mathieu Chalouni, Julià Blanco, et al.
Neurology|July 10, 2015
Diabetes and cognitive decline in a French cohort of patients infected with HIV-1Carole Dufouil, Laura Richert, Rodolphe Thiébaut, et al.
NPJ Vaccines|January 30, 2021
Durable natural killer cell responses after heterologous two-dose Ebola vaccinationHelen R Wagstaffe, Giada Susannini, Rodolphe Thiébaut, et al.
Vaccines|June 24, 2022
NK Cell Subset Redistribution and Antibody Dependent Activation after Ebola Vaccination in AfricansHelen R Wagstaffe, Omu Anzala, Hannah Kibuuka, et al.
AIDS (London, England)|June 14, 2013
Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteersLaura Richert, Sophie Hue, Hakim Hocini, et al.
Nature Communications|September 3, 2024
Long-term cellular immunity of vaccines for Zaire Ebola Virus DiseasesAurélie Wiedemann, Edouard Lhomme, Mélanie Huchon, et al.
The Journal of Antimicrobial Chemotherapy|November 23, 2019
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trialLaura Dickinson, Rohan Gurjar, Wolfgang Stöhr, et al.
Journal of Reproductive Immunology|June 11, 2018
Innate immune responses to toll-like receptor stimulation are altered during the course of pregnancySusanne Maria Ziegler, Cai Niklaas Feldmann, Sven Hendrik Hagen, et al.
Plos One|August 10, 2017
Proliferative capacity exhibited by human liver-resident CD49a+CD25+ NK cellsGlòria Martrus, Tobias Kautz, Sebastian Lunemann, et al.
Plos One|December 1, 2018
HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidatesAnne-Laure Flamar, Henri Bonnabau, Sandra Zurawski, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Journal of Acquired Immune Deficiency Syndromes (1999)|December 22, 2020
Influence of the Antiretroviral Regimen on the Early Changes in Plasma HIV RNA and Immune Activation at Initiation of Antiretroviral Therapy in Naïve HIV-1-Infected PatientsAssia Samri, Mathieu Chalouni, Julià Blanco, et al.
Neurology|July 10, 2015
Diabetes and cognitive decline in a French cohort of patients infected with HIV-1Carole Dufouil, Laura Richert, Rodolphe Thiébaut, et al.
NPJ Vaccines|January 30, 2021
Durable natural killer cell responses after heterologous two-dose Ebola vaccinationHelen R Wagstaffe, Giada Susannini, Rodolphe Thiébaut, et al.
Vaccines|June 24, 2022
NK Cell Subset Redistribution and Antibody Dependent Activation after Ebola Vaccination in AfricansHelen R Wagstaffe, Omu Anzala, Hannah Kibuuka, et al.
AIDS (London, England)|June 14, 2013
Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteersLaura Richert, Sophie Hue, Hakim Hocini, et al.
Nature Communications|September 3, 2024
Long-term cellular immunity of vaccines for Zaire Ebola Virus DiseasesAurélie Wiedemann, Edouard Lhomme, Mélanie Huchon, et al.
The Journal of Antimicrobial Chemotherapy|November 23, 2019
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trialLaura Dickinson, Rohan Gurjar, Wolfgang Stöhr, et al.
Journal of Reproductive Immunology|June 11, 2018
Innate immune responses to toll-like receptor stimulation are altered during the course of pregnancySusanne Maria Ziegler, Cai Niklaas Feldmann, Sven Hendrik Hagen, et al.
Plos One|August 10, 2017
Proliferative capacity exhibited by human liver-resident CD49a+CD25+ NK cellsGlòria Martrus, Tobias Kautz, Sebastian Lunemann, et al.
Plos One|December 1, 2018
HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidatesAnne-Laure Flamar, Henri Bonnabau, Sandra Zurawski, et al.
Pageof 10